These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 25634007

  • 1. Central versus Peripheral Tumor Location: Influence on Survival, Local Control, and Toxicity Following Stereotactic Body Radiotherapy for Primary Non-Small-Cell Lung Cancer.
    Park HS, Harder EM, Mancini BR, Decker RH.
    J Thorac Oncol; 2015 May; 10(5):832-837. PubMed ID: 25634007
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy.
    Kelley KD, Benninghoff DL, Stein JS, Li JZ, Byrnes RT, Potters L, Knisely JP, Zinkin HD.
    Radiat Oncol; 2015 May 28; 10():120. PubMed ID: 26018408
    [Abstract] [Full Text] [Related]

  • 5. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
    Davis JN, Medbery C, Sharma S, Pablo J, Kimsey F, Perry D, Muacevic A, Mahadevan A.
    Radiat Oncol; 2015 May 15; 10():113. PubMed ID: 25975848
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer Tumors Greater Than 5 cm: Safety and Efficacy.
    Woody NM, Stephans KL, Marwaha G, Djemil T, Videtic GM.
    Int J Radiat Oncol Biol Phys; 2015 Jun 01; 92(2):325-31. PubMed ID: 25841625
    [Abstract] [Full Text] [Related]

  • 8. Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a "no fly zone".
    Chang JY, Li QQ, Xu QY, Allen PK, Rebueno N, Gomez DR, Balter P, Komaki R, Mehran R, Swisher SG, Roth JA.
    Int J Radiat Oncol Biol Phys; 2014 Apr 01; 88(5):1120-8. PubMed ID: 24661665
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tumor Control and Toxicity after SBRT for Ultracentral, Central, and Paramediastinal Lung Tumors.
    Nguyen KNB, Hause DJ, Novak J, Monjazeb AM, Daly ME.
    Pract Radiat Oncol; 2019 Mar 01; 9(2):e196-e202. PubMed ID: 30496842
    [Abstract] [Full Text] [Related]

  • 12. Salvage stereotactic body radiation therapy (SBRT) for local failure after primary lung SBRT.
    Hearn JW, Videtic GM, Djemil T, Stephans KL.
    Int J Radiat Oncol Biol Phys; 2014 Oct 01; 90(2):402-6. PubMed ID: 25017480
    [Abstract] [Full Text] [Related]

  • 13. 30 Gy or 34 Gy? Comparing 2 single-fraction SBRT dose schedules for stage I medically inoperable non-small cell lung cancer.
    Videtic GM, Stephans KL, Woody NM, Reddy CA, Zhuang T, Magnelli A, Djemil T.
    Int J Radiat Oncol Biol Phys; 2014 Sep 01; 90(1):203-8. PubMed ID: 25015198
    [Abstract] [Full Text] [Related]

  • 14. Lung stereotactic body radiation therapy for elderly patients aged ≥ 80 years with pathologically proven early-stage non-small cell lung cancer: a retrospective cohort study.
    Watanabe K, Katsui K, Sugiyama S, Yoshio K, Kuroda M, Hiraki T, Kiura K, Maeda Y, Toyooka S, Kanazawa S.
    Radiat Oncol; 2021 Feb 23; 16(1):39. PubMed ID: 33622369
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study.
    Fakiris AJ, McGarry RC, Yiannoutsos CT, Papiez L, Williams M, Henderson MA, Timmerman R.
    Int J Radiat Oncol Biol Phys; 2009 Nov 01; 75(3):677-82. PubMed ID: 19251380
    [Abstract] [Full Text] [Related]

  • 17. Risk-adapted stereotactic body radiation therapy for central and ultra-central early-stage inoperable non-small cell lung cancer.
    Meng MB, Wang HH, Zaorsky NG, Sun BS, Zhu L, Song YC, Li FT, Dong Y, Wang JS, Chen HM, Yu XY, Yuan ZY.
    Cancer Sci; 2019 Nov 01; 110(11):3553-3564. PubMed ID: 31464032
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.